The Role of Matrix Metalloproteinases on the Primary Teeth Pulpotomy Treatments
Condition: Reversible Pulpitis
MeSH terms: Pulpitis
Study type: Interventional
Phase: Phase 1/Phase 2

Summary: 
      Matrix metalloproteinases (MMPs) are important zinc enzyme group that responsible for
      reducing extracellular matrix components. It has been reported that MMPs play an important
      role in pulpal inflammation. The aims of this in vivo study was to compare the expression
      levels of MMP-2, -8 and -9 in primary molars with reversible and irreversible pulpitis and to
      compare the clinically and radiographically success of MTA and Biodentine materials at the
      end of 18 months.
    

Detailed description: 
      A total of 63 mandibular primary second molar teeth of 57 healthy and cooperative children
      aged between 5-10 years were included in this study. The Ethical Committee of the Medical
      Faculty of Ege University approved the study (Reference No: 16-7/14). Detailed treatment plan
      was explained to the children and the parents and written informed consents were obtained.

      Periapical radiographs were obtained pre-operatively. Patients with a tooth showing clinical
      or radiographic evidence of a deep carious lesion extending close or into the pulp chamber
      were considered for potential inclusion.

      The teeth were assigned to different groups according to the clinical diagnosis. The
      diagnosis were based on strict clinical and radiographic criteria. When the dental pulp was
      exposed during caries removal, the following clinical and radiographic diagnostic criteria
      were applied; Group I (teeth with reversible pulpitis): Slight clinical symptoms of minor
      intensity, slightly exaggerated reaction to cold or sweet stimuli, no history of pain, no
      sensitivity to chewing or percussion, bleeding time from the exposed pulp tissue less than 5
      minutes, and no widening of the periodontal ligament space. In pulpotomy group teeth with
      pulpal exposure smaller than a pinpoint, teeth with purulent/viscous, dark colored exudate
      detected at the exposure site, and necrotic teeth were excluded.

      Group II (teeth with irreversible pulpitis): Spontanous pain, sensitivity to chewing or
      percussion, bleeding time from the exposed pulp tissue more than 5 minutes, and widening of
      the periodontal ligament space, periapical lesion.

      For ethical reasons, there was no control group with blood samples from healthy caries-free
      teeth. All primary molars were distributed between the two treatment groups as pulpotomy
      (Group I, n=42) and pulpectomy (Group II, n=21).

      The pulpotomy procedures and all sampling were performed by the same operator (H.E.G.)
      following the procedure as follows: local anesthesia (2% lidocaine (1:000,000)-Jetokain
      Simplex, Adeka, Turkey) was administered, and teeth were isolated by a rubberdam (Roeko
      Dental Dam, Coltane, Whaledent, Germany). The carious dentin was removed from the cavity,
      working from the periphery towards the center using a low-speed round bur (no:4). The roof of
      the pulp chamber was removed, and coronal pulp tissue was taken using a sharp excavator. All
      pulp samples were placed in 1 ml Tri Pure Reagent transport medium in pre-weighed Eppendorf
      tubes. The samples were weighed again and the weights were noted before storing at -80°C
      until the laboratory procedures. In pulpectomy group (Group II), all sampling procedures were
      performed as same in pulpotomy group.

      In Group I, after removal of the coronal pulp, the cavity was irrigated with sterile saline,
      and initial bleeding was controlled by placing sterile cotton pellets moisturized with saline
      over the radicular pulp stump exerting slight pressure and waiting for 5 min. The teeth for
      which hemostasis at the canal orifices could be achieved in 5 min were included to this
      group. The randomization was performed as two groups in a 1 : 1 ratio by using free online
      software (http://www.random.org). Following the randomization procedure, patients were
      assigned sequential numbers in the order of enrolment and the operator was informed about the
      material, either with MTA (n=21) or with Biodentine (n=21).

      MTA Group: According to the manufacturer's instructions, MTA (Pro Root White MTA, Dentsply,
      Tulsa Dental Specialties, USA) powder was mixed with sterile water in a 3:1 powder/water
      ratio to obtain a thick creamy paste, then placed on the floor of the pulp chamber. The MTA
      mixture was covered with a moistened cotton pellet and then temporarily sealed using glass
      ionomer cement (GIC-Ketac Molar Easymix, 3M Espe, Seefeld, Germany) until the second visit.

      Biodentine Group: Biodentine (Septodont, Saint-Maur-des-Fossés, France) capsule was gently
      tapped on a hard surface to diffuse powder, five drops of liquid from the single dose
      dispenser were poured into the capsule and then mixed with 4200 rpm 30 seconds and placed
      over the pulp stumps using an appropriate spatula advised by the manufacturer. After allowing
      Biodentine to set for 12 min, the teeth were temporarily sealed with GIC as same in MTA
      group.

      After 24 hours, the teeth in both groups were restored with preformed stainless -steel crowns
      (3M Espe, Stainless Steel Crowns, Seefeld, Germany). The participants were recalled at 6, 12
      and 18 months after the treatment. At each follow-up visit, clinical and radiographic
      examinations were performed by two calibrated blinded examiners. All teeth were evaluated
      clinically and radiographically according to the criteria: (1) absence of spontaneous pain
      and/or sensitivity to pressure, (2) absence of sinus, fistula, edema, and/or abnormal
      mobility, (3) absence of radiolucency at the interradicular and/or periapical regions, (4)
      absence of internal or external root resorption. The absence of spontaneous pain, pathologic
      mobility, tenderness to percussion, swelling, fistula, and gingival inflammation was
      considered as a clinical success, whereas the absence of internal/external root resorption
      and periapical/furcal radiolucency was considered as a radiographic success. Calcific
      metamorphosis of the pulp was not considered as a failure.

      Pulp tissue was washed in phosphate-buffered saline (Gibco, Invitrogen, Karlsruhe, Germany)
      for 1 min, cut into small pieces, transferred to cell-culture plates and incubated with
      Dulbecco's modified Eagle's medium containing 10% fetal bovine serum (Gibco BRL, Life
      Technologies, Grand Island, NY, USA), penicillin-G (100 U⋅mL), streptomycin (100 µg⋅mL) and
      Fungizone (0.25 g⋅mL) (GeminiBio-Products Inc., Woodland, CA, USA) at 37 °C in a humidified
      atmosphere of 5% CO2. Migration of cells from the pulpal tissue occurred 1 week later, and
      cultures were established and maintained in standard culture medium. Medium was refreshed
      three times per week, and cells were split, after reaching confluence. Pulp cells between the
      third and eighth passages were used in this study (ref).

      RNA was extracted from the treated cells using RNAiso Plus (TaKaRa Bio, Shiga, Japan). cDNA
      was synthesized from 400 ng of total RNA using the PrimeScript RT reagent kit (TaKaRa Bio,
      Otsu, Japan) according to the manufacturer's instructions. One-tenth of the cDNA obtained was
      added for a final volume of 20 µL for each reaction containing SYBR Green I (TaKaRa Bio,
      Shiga, Japan). The primers for MMP-2, -8 and -9 were as follows (sense/antisense):

      MMP-2: 5'-ATC CTG GCT TTC CCA AGC TC-3'/3'-CAC CCT TGA AGA AGT AGC TGT G-5'.
      MMP-8:5'-CTGTTGAAGGCCTAGAGCTGCTGCTCC3'/5'CATCTTCTCTTCAAACTCTACCC-3'. MMP-9: 5'-GGG CTT AGA
      TCA TTC CTC AGT G-3'/3'-GCC ATT CAC GTC GTC CTT AT-5'. (ref) Reactions were run on an ABI
      Step One real-time PCR system (Applied Biosystems, Foster City, CA, USA) with the following
      program: 45 cycles of 95 °C for 10 s, 60 °C for 15 s and 72 °C for 20 s. For relative
      comparisons of each gene, the investigators analysed the threshold cycle (Ct) value of the
      real-time PCR data using the 2-ΔΔCt method.20 The PCR products were analyzed on a 1.5%
      agarose gel containing 1 pg/mL ethidium bromide, which attaches to nucleic acids, allowing
      the PCR products to be visualized under UV light. The gel was photographed to allow the
      products to be quantitated as described below. After finding the linear portion for each set
      of primers for quantitation of the products, the investigators quantitated the products with
      an image processing and analyzing program (ScionImage PC, Scion Corporation, Frederick, MD,
      USA) to analyze the expression of MMP-2, -8 and -9.(ref) Statistical Analysis The statistical
      analysis was performed using SPSS for Windows version 25.0 (SPSS, Chicago, IL, USA). A
      p-value of <0.05 was considered to be statistically significant.

      Data were analysed using a Fisher Exact Test in addition to chi-square tests to perform
      inter- and intra- group comparisons, respectively.

      The Fisher's Exact Test was used for testing the levels of MMP-2, -8, -9 expression between
      the reversible and irreversible pulpitis groups.

      The 6, 12 and 18 months clinically and radiographically success of MTA and Biodentine
      materials were tested by chi-square test.

      Mann Whitney U test was used in comparing the MMP-2, -8, -9 expressions between successful
      and failed pulpotomy groups.
    

Intervention name(s): Matris metalloproteinase -2, -8, -9 expressions
Intervention type(s): Diagnostic Test
Intervention description(s): . The aims of this in vivo study was to compare the expression levels of MMP-2, -8 and -9 in primary molars with reversible and irreversible pulpitis and to compare the clinically and radiographically success of MTA and Biodentine materials at the end of 18 months.
Other intervention name(s): MTA and Biodentine
Allocation: Randomized
Intervention model: Parallel Assignment
Intervention model description: Experimental: Biodentine Dental materials
Interventions:
Drug: Biodentine Drug: ProRoot (Aggregate) Experimental: ProRoot MTA Dental Materials
Interventions:
Drug: Biodentine Drug: ProRoot (Aggregate)
Masking: Single (Outcomes Assessor)
Primary purpose: Treatment
Keywords: MTA; Biodentine; Pulpotomy; Matrix metalloproteinase